When the coronavirus hit, the Serum Institute of India, the world’s largest vaccine maker, seemed uniquely positioned to help. It struck a deal with AstraZeneca, promising a billion vaccine doses to low- and middle-income nations.
Earlier this year, a ban instituted by Prime Minister Narendra Modi put a stop to those plans.
What has that meant for the nati ... Show More
Today
The Fight Tearing Apart Silicon Valley
For years, a debate has been simmering in Silicon Valley over the right way to build artificial intelligence. Should it be open and free for anyone to use, or should we tightly control how it’s made and who can access it? Mike Isaac, who covers technology for The New York Times, ... Show More
26m 51s
Jul 29
Israel, AIPAC and Difficult Questions for Democrats
The American Israel Public Affairs Committee, a pro-Israel lobbying group known as AIPAC, has spent a record amount of money in this year’s midterm elections to either oust or support candidates based on their support of Israel. Jonathan Mahler, a writer for The New York Times Ma ... Show More
39m 30s
Jan 2021
EU vaccine export tensions, a serious look at stock prices, India’s farmers
<p>Facing a shortfall in vaccine supplies and slow pace of vaccinations, the EU is debating how to restrict exports of coronavirus vaccines, India’s farmers are angry about agricultural reforms that could erode the state-run model and boost private agribusiness, and the plant-bas ... Show More
9m 51s
Mar 2021
How to Vaccinate the Entire World
As wealthier nations have bought up most of the world’s supply of vaccines, many lower and middle-income countries have been left behind. Today, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta speaks to Dr. Krishna Udayakumar, Director of the Duke University Global Health Inno ... Show More
16m 37s